Comparative growth performance of backgrounded beef heifers treated with an injectable fixed-dose combination (0.2 mg/kg doramectin + 6.0 mg/kg levamisole hydrochloride) or single-active (0.2 mg/kg ivermectin) endectocide.

Autor: DeRosa AA; Zoetis, 333 Portage Street, Kalamazoo, MI 49007, USA. Electronic address: andrew.derosa@zoetis.com., Holzmer S; Zoetis, 333 Portage Street, Kalamazoo, MI 49007, USA., Ball JJ; Zoetis, 333 Portage Street, Kalamazoo, MI 49007, USA., Watkins LP; Zoetis, 333 Portage Street, Kalamazoo, MI 49007, USA., Blanding M; Zoetis, 333 Portage Street, Kalamazoo, MI 49007, USA., Alley M; Zoetis, 333 Portage Street, Kalamazoo, MI 49007, USA., Short TH; Zoetis, 333 Portage Street, Kalamazoo, MI 49007, USA., Bechtol DT; Agri Research, LLC, 17001 Hope Road, Canyon, TX 79015, USA., Waite AR; Agri Research, LLC, 17001 Hope Road, Canyon, TX 79015, USA., Rigoni EJ; Zoetis, 333 Portage Street, Kalamazoo, MI 49007, USA., Tena JK; Zoetis, 333 Portage Street, Kalamazoo, MI 49007, USA.
Jazyk: angličtina
Zdroj: Veterinary parasitology [Vet Parasitol] 2023 Nov; Vol. 323S, pp. 110054. Date of Electronic Publication: 2023 Oct 23.
DOI: 10.1016/j.vetpar.2023.110054
Abstrakt: Gastrointestinal nematodes (GINs) can negatively impact all production classes of cattle, particularly growing cattle. A global decline in efficacy of broad-spectrum single-active anthelmintics requires alternative GIN control methods without the aid of novel drug classes. Here, we present a new fixed-dose combination injectable (FDCI) endectocide for cattle that combines doramectin (5 mg/ml) and levamisole hydrochloride (150 mg/ml). A 56-day comparative performance confinement backgrounding trial was conducted in stocker beef heifers (n = 1548) with confirmed GIN infections to (1) compare the Day 14 post-treatment effectiveness of the new FDCI endectocide to pen mates treated with the injectable single-active endectocide ivermectin, as evidenced by fecal egg counts (FECs) conducted for a randomly selected subset (10%) of both treatment groups, and (2) determine if the greater GIN control by the FDCI evidenced in the subsample improved growth performance in all FDCI-treated heifers. Heifers were procured in four cohorts, with a 10-week timeframe between enrollment of the first and last cohort. Treatment groups were comingled within dirt-floor pens (n = 31; 7-8 per cohort) and offered a standard backgrounding diet ad libitum for the study duration. Heifers with enrollment FEC ≥ 30 eggs per gram (EPG) were randomly allocated to receive the FDCI (n = 773) or ivermectin (n = 775) on Day 0. Day 0 FECs conducted on 10% of enrolled heifers (FDCI, n = 78; ivermectin, n = 79) were not different between treatment groups (p = 0.491). Day 14 FECs for the same heifers were reduced compared to Day 0 within each treatment group. Heifers given the FDCI had lower Day 14 AM FECs and higher FEC reduction test (FECRT) result (0.07 EPG; 0.999) than ivermectin-treated heifers (21.58 EPG; FECRT = 0.850). Mean body weight (BW) was not different between treatment groups on Day 0 (p = 0.2762) and Day 14 (p = 0.2010) but was significantly greater (p = 0.0007) for FDCI-treated heifers compared to ivermectin-treated heifers on Day 56. Compared to ivermectin-treated heifers, overall average daily gain from all evaluation periods (Day 0-14, Day 14-56, and Day 0-56) was greater (p ≤ 0.0052) in FDCI-treated heifers, and FDCI-treated heifers had 4.223 kg greater total weight gain over the 56-day study. The FDCI (0.2 mg/kg doramectin + 6.0 mg/kg levamisole hydrochloride) was highly effective in reducing GIN infections and thus promoted improved growth performance in beef heifers over a 56-day backgrounding period.
Competing Interests: Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Andrew A. DeRosa reports a relationship with Zoetis Inc that includes: employment. Susan Holzmer reports a relationship with Zoetis Inc that includes: employment. Jase J. Ball reports a relationship with Zoetis Inc that includes: employment. Landon P. Watkins reports a relationship with Zoetis Inc that includes: employment. Mitchell Blanding reports a relationship with Zoetis Inc that includes: employment. Mark Alley reports a relationship with Zoetis Inc that includes: employment. Thomas H. Short reports a relationship with Zoetis Inc that includes: employment. David T. Bechtol reports a relationship with Agri Research LLC that includes: employment. Audie R. Waite reports a relationship with Agri Research LLC that includes: employment. Elizabeth J Rigoni reports a relationship with Zoetis Inc that includes: employment. Jezaniah K Tena reports a relationship with Zoetis Inc that includes: employment.
(Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: